| 1. |
Kumarvelu S, Prasad K, Khosla A, et al. Randomized controlled trial of dexamethasone in tuberculous meningitis. Tuber Lung Dis, 1994, 75(3): 203-207.
|
| 2. |
Toppet M, Malfroot A, Derde MP, et al. Corticosteroids in primary tuberculosis with bronchial obstruction. Arch Dis Child, 1990, 65(11): 1222-1226.
|
| 3. |
Park IW, Choi BW, Hue SH. Prospective study of corticosteroid as an adjunct in the treatment of endobronchial tuberculosis in adults. Respirology, 1997, 2(4): 275-281.
|
| 4. |
Anonymous. Study of chemotherapy regimens of 5 and 7 months’ duration and the role of corticosteroids in the treatment of sputumpositive patients with pulmonary tuberculosis in South India. Tubercle, 1983, 64(2): 73-91.
|
| 5. |
Bilaceroglu S, Perim K, Buyuksirin M, et al. Prednisolone: a beneficial and safe adjunct to antituberculosis treatment? A random-ized controlled trial. Int J Tuberc Lung Dis, 1999, 3(1): 47-54.
|
| 6. |
Strang JIG, Kakaza HHS, Gibson DG, et al. Controlled trial of prednisolone as adjuvant in treatment of tuberculous constrictive pericarditis in Transkei. Lancet, 1987, 2(8573): 1418-1422.
|
| 7. |
Strang JIG, Kakaza HHS, Gibson DG, et al. Controlled clinical trial of complete open surgical drainage and of prednisolone in treatment of tuberculous pericardial effusion in Transkei. Lancet, 1988, 2(8614): 759-764.
|
| 8. |
Mayosi BM, Ntsekhe M, Volmink JA, et al. Interventions for treating tuberculous pericarditis. Cochrane Database of Systematic Reviews 2002, Issue 4.
|
| 9. |
Hakim J, Ternouth I, Mushangi E, et al. A. Double blind randomised placebo controlled trial of adjuvant prednisolone in the treatment of effusive tuberculous pericarditis in HIV seropositive patients. Heart, 2000, 84: 183-188.
|
| 10. |
Strang JI, Nunn AJ, Johnson DA, et al. Management of tuberculous constrictive pericarditis and tuberculous pericardial effusion in Transkei: results at 10 years follow-up. QJM, 2004 , 97(8): 525-535.
|
| 11. |
Girgis NI, Farid Z, Kilpatrick ME, et al. Dexamethasone adjunctive treatment for tuberculous meningitis. Pediatr Infect Dis J, 1991, 10(3): 179-183.
|
| 12. |
Thwaites GE, Nguyen DB, Nguyen HD, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med, 2004, 351(17): 1741-1751.
|
| 13. |
O’Toole RD, Thornton GF, Mukherjee MK, et al. Dexamethasone in tuberculous meningitis. Relationship of cerebrospinal fluid effects to therapeutic efficacy. Ann Intern Med, 1969, 70(1): 39-47.
|
| 14. |
Schoeman JF, Van Zyl LE, Laubscher JA, et al. Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcome in young children with tuberculous meningitis. Pediatrics, 1997, 99(2): 226-231.
|
| 15. |
Kumarvelu 1994 [published and unpublished data] Kumarvelu S, Prasad K, KhoslaA, et al. Randomized controlled trial of dexamethasone in tuberculous meningitis. Tuber Lung Dis, 1994, 75(3): 203-207.
|
| 16. |
Prasad K, SinghMB. Corticosteroids for managing tuberculous meningitis. Cochrane Database of Systematic Reviews 2008, Issue 1. Art.
|
| 17. |
Centers for Disease Control and Prevention. Treatment of Tuberculosis, American Thoracic Society, CDC, and Infectious Diseases Society of America. MMWR 2003; 52 (No. RR-11): [inclusive page numbers].
|
| 18. |
National Collaborating Centre for Chronic Conditions. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. London (UK): Royal College of Physicians; 2006. 215.
|
